Published in Medical Imaging Business Week, March 16th, 2006
"The objective of this study was to determine the accuracy of (early) response measurements using (18)FDG-PET with respect to survival of patients with stage IIIA-N2 NSCLC undergoing induction chemotherapy (IQ, with a comparative analysis of PET methods. In a prospective multicenter study, PET was performed in patients before IC and after 1 and 3 cycles. Computed tomography (CT) was performed before...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Imaging Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.